Allantoin is a widely used cosmetic ingredient known for its skin-soothing, moisturizing, and healing effects. Originally derived from the comfrey plant, it is now synthetically produced for consistent use in skincare. This article explores its cellular mechanism of action, clinical efficacy, regulatory status, and key formulation considerations.
Cosmetic Ingredients Series
Below is a list of the most recent articles about cosmetic ingredients, to view the full list, click here.
What Is Allantoin?
Chemically, allantoin is a diureide of glyoxylic acid (5-ureidohydantoin), and it appears as a white, odorless, crystalline powder that is soluble in water. It is a product of purine metabolism in most mammals (excluding humans and other higher primates), where it results from the oxidation of uric acid by urate oxidase.
In cosmetics, allantoin is primarily included in concentrations ranging from 0.1–0.5% in topical preparations
Mechanism of Action
Keratolytic Activity
Allantoin facilitates desquamation by promoting the softening and shedding of the stratum corneum. It disrupts intercellular cohesion in corneocytes, aiding in the removal of dead skin cells and enhancing the skin’s smoothness.
Proliferation and Regeneration
Studies indicate that allantoin stimulates cell proliferation, particularly of keratinocytes and fibroblasts. This has been demonstrated in in vitro models, where allantoin-treated fibroblasts showed increased DNA synthesis and mitotic activity. This regeneration is crucial for wound healing and epidermal renewal (non-cosmetic functions).
Anti-inflammatory Action
Allantoin modulates inflammatory pathways by downregulating pro-inflammatory cytokines such as TNF-α and IL-6. It is believed to inhibit NF-κB signaling in immune cells, thereby reducing oxidative stress and inflammation in the dermis.
Moisturisation and Barrier Function
Allantoin enhances skin hydration by increasing the water content of the extracellular matrix. It is thought to upregulate aquaporin-3 and filaggrin expression, key proteins involved in skin moisture retention and barrier integrity.
Short-Term Benefits
- Reduced skin irritation and erythema.
- Improved hydration and elasticity.
- Enhanced healing of minor abrasions, burns, and irritations.
Long-Term Benefits
- Restoration of the epidermal barrier function.
- Reduction of chronic inflammation in sensitive or compromised skin.
- Improvement in signs of aging through consistent epidermal turnover.
Clinical Evidence
Numerous studies have assessed the efficacy of allantoin in dermatological contexts:
- A randomized controlled trial comparing allantoin-containing creams with hydrocortisone in diaper dermatitis found allantoin to significantly reduce erythema and lesion scores, comparable to low-potency steroids.
- In patients with radiation-induced dermatitis, allantoin-containing emulsions led to improved skin healing and reduced discomfort.
- A double-blind trial involving subjects with mild acneiform lesions showed that an allantoin and panthenol combination led to significant lesion count reduction and skin texture improvement after 4 weeks.
While many of these studies involve formulations with multiple actives, allantoin’s contribution is supported by consistent in vitro and in vivo results demonstrating its bioactivity and skin-compatible nature.
Regulatory Status
Allantoin is considered safe for use in cosmetics globally, supported by a long history of use and robust toxicological data:
- United States (FDA): Recognized as an OTC skin protectant at concentrations of 0.5% to 2.0% under 21 CFR 347.10. It is included in monographs for treatment of minor skin irritations and abrasions.
- European Union: Listed in the CosIng database as a skin-conditioning agent and approved without restrictions based on the safety assessment of allantoin.
- Japan and ASEAN: Included in positive lists of cosmetic ingredients with no special limitations.
Toxicological reviews have shown allantoin to be non-mutagenic, non-sensitizing, and non-irritating at standard cosmetic concentrations. Animal and human patch tests confirm its excellent dermal tolerance, even in sensitive populations such as infants and the elderly.
Formulation Considerations
Allantoin is water-soluble and stable over a wide pH range (4.0–8.0), making it compatible with most cosmetic emulsions and aqueous systems. However, it has limited solubility (~0.5% in water at room temperature), which must be considered during formulation. Solutions often require heating to fully dissolve allantoin.
- Protect from high temperatures and acidic environments (pH < 3.5) to avoid degradation.
- Combine with other soothing agents like panthenol, bisabolol, or niacinamide for synergistic effects.
- Use in emulsions, gels, or serums aimed at post-procedure, sensitive, or damaged skin.
